Étude de cas

Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization Program

PATH

Switching from one vaccine product to another can have a significant impact on a country’s budget. For Palestine’s rotavirus vaccination program, a switch paid off.

This brief describes an economic analysis conducted by PATH in partnership with the Rostropovich-Vishnevskaya Foundation and the Palestinian Ministry of Health to assess the economic implications of Palestine’s switch from ROTARIX to ROTAVAC.

Auteurs

Langues

Année de publication

2020

Type

Étude de cas

Catégories

  • Gestion de programme

Maladies

  • Rotavirus

Organisations

  • PATH

Mots-clés

  • Planification, budgétisation et financement

PORTFOLIO-LESSONS

Cette ressource apparaît sur le Thème suivant:

Cette ressource est incluse dans le tableau suivant:

TitreAuteurAnnéeTypeLangue
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportAnglais
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRusse
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabe, Anglais, Russe, Français
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI Research & Training Institute, Inc2019Case studyAnglais
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleAnglais
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyAnglais

Ajouté par: Laura Kallen

Ajouté le: 2020-12-17 09:31:04

Consultations: 2086

Liens

Ajouter une ressource